Melatonin and Hyaluronic Acid in Maxillary Sinus Augmentation
NCT ID: NCT04625179
Last Updated: 2020-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2019-12-03
2020-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
the effect of melatonin and hyaluronic acid on the newly formed bone in maxillary sinus augmentation was evaluated
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study group will receive melatonin and hyaluronic acid after sinus membrane elevation and simultaneous implant placement while the control group will not receive any materials after sinus membrane elevation and simultaneous implant placement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Melatonin and hyaluronic acid and sinus membrane elevation
melatonin and hyaluronic acid will be placed after maxillary sinus membrane elevation and simultaneous dental implants placement
Melatonin and hyaluronic acid and sinus membrane elevation
3 mg melatonin powder mixed with 0.2% hyaluronic acid gel will be placed to fill the sinus space and around the implant apex.
sinus membrane elevation without any materials
no materials will be placed after maxillary sinus membrane elevation and simultaneous dental implants.
sinus membrane elevation without any materials
No materials will be placed at the sinus space.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Melatonin and hyaluronic acid and sinus membrane elevation
3 mg melatonin powder mixed with 0.2% hyaluronic acid gel will be placed to fill the sinus space and around the implant apex.
sinus membrane elevation without any materials
No materials will be placed at the sinus space.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with missed one or more of posterior teeth with minimum residual bone height 5 mm
* Adequate inter-occlusal space of at least 8 mm
Exclusion Criteria
* Previous sinus surgery like the Caldwell-Luc operation.
* History of chemotherapy or radiotherapy to maxilla.
* Presence of Underwood's septa/severe sinus floor convolutions.
* Systemic disease affecting bone metabolism.
* Uncontrolled diabetes mellitus.
* Heavy smokers.
* Para functional habits.
30 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hams Hamed Abdelrahman
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hams Hamed Abdelrahman
Assistant lecturer of DPH and Clinical statistician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry, Alexandria University
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Maxillary sinus augmentation
Identifier Type: -
Identifier Source: org_study_id